Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Buildit, I’m enjoying this back and forth (de

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36566
(Total Views: 316)
Posted On: 01/09/2021 4:12:35 PM
Posted By: Assiduous
Re: Buildit #25232
Buildit,

I’m enjoying this back and forth (debate?) and will run with your counter post. 150,000,000 total float (outstanding) shares after the IPO @ $4/share. GNBT owns 364,003,151 NGIO shares (current 10-Q), which means it doesn’t own 36,296,849 shares (400,300,000 - 364,003,151 = 36,296,849). That leaves 113,703,151 to be divided up between GNBT and the IPO investors (150,000,000 - 36,296,849 = 113,703,151). Whether the IPO shares comes from GNBT or the NGIO treasury (new issue) the effect is the same, GNBT has further reduction in NGIO control (and net value to GNBT). How many share do you want to IPO offer? How about a meager 10,000,000 from the NGIO treasury. NGIO get $40,000,000 working capital and GNBT would have 103,703,151 NGIO shares (113,703,151 - 10,000,000 IPO shares). As a result, GNBT ownership is reduced to 69%. I suppose that is acceptable if Joe likes it. But that leaves far fewer shares of NGIO that GNBT can use (sell/trade) to raise capital for future projects. Remember that all the NGIO revenue stream (vaccines etc.) is the property of NGIO and its shareholders, not GNBT or its shareholders. GNBT pps is solely dependent on the value of its holdings and any shares at their disposal. I will assume that Joe and his team was well aware of all of this when he decided to initially issue 400,000,000 (later an additional 300,000) NGIO shares from the 750,000,000 total corporate shares. He could have just issues less shares to begin with.

PS: I’m a freebee poster and can’t remember how many posts I get daily, so any more back and forth may have to wait until tomorrow.


(3)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us